Topics

vaccine composition

The manner in which the parts of a vaccine are combined or related.

vaccines
2.4 Nonclinical Overview AZD1222
2.5 Clinical Overview: AZD1222 Marketing Authorisation Application - Primary Analysis (Data Cut-off 07 December 2020)
A cautionary note: Toxicity of polyethylene glycol 200 injected intraperitoneally into mice
An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine based on the European Medicines Agency’s Public Assessment Report (EPAR)
Assessment report: COVID-19 Vaccine Moderna
Cationic compounds used in lipoplexes and polyplexes for gene delivery
CAUGHT ON CAMERA: W.H.O SCIENTISTS QUESTION SAFETY OF VACCINES
Congressional-hearing statement of Dr. Robert Malone on the presence of DNA in mRNA vaccines
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
COVID-19 mRNA vaccines contain excessive quantities of bacterial DNA: evidence and implications
Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.
First case of postmortem study in a patient vaccinated against SARS-CoV-2
Florida State Surgeon General Calls for Halt in the Use of COVID-19 mRNA Vaccines
Form S-1 Registration Statement Under the Securities Act of 1933: BioNTech SE
Form S-1 Registration Statement Under the Securities Act of 1933: Moderna, Inc.
Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity
Graphene and graphene oxide as nanomaterials for medicine and biology application
Graphene and the Immune System: A Romance of Many Dimensions
How Bad is My Batch? Batch codes and associated deaths, disabilities and illnesses for Covid 19 Vaccines
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
Long Term Follow-Up After Administration of Human Gene Therapy Products Guidance for Industry
mRNA Platform: Enabling Drug Discovery & Development
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
Panel of doctors in Nashville, Tennessee
Rapid Response to: Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
Response: Ed Humpherson to Norman Fenton, Martin Neil, Clare Craig and Scott McLachlan: ONS Deaths by Vaccination Status statistics
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
Session 86 of the Corona Investigative Committee
Statement by Professor Christian Perronne at Parliamentary Hearing in Luxemburg
Testimony of Dr. Aditi Bhargava
The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
The EMA covid-19 data leak, and what it tells us about mRNA instability
The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review
Toxicity of cationic lipids and cationic polymers in gene delivery
Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Vaccinating people who have had covid-19: why doesn’t natural immunity count in the US?
Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination
1470